17206-Ovarian Cancer-NA-1240

Ovarian Cancer

A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)

  • Details

ClinicalTrials.gov ID: NCT03639246
Diagnosis Type: NA
USOR Number:

  • Address

603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206

Search by practice name, trial titles, indicators and specific disease types.